Firm
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Rajiv Suri of RNA, Technology and IP Attorneys outline how the Advertising Standards Council of India have reacted to increased online gaming trends during the COVID-19 pandemic -
Sponsored by MaiwaldMarco Stief of Maiwald takes a closer look at the key elements of the scientific research initiative that succeeded the Horizon 2020 framework programme
-
Sponsored by IncoproColette Durst explains how she restructured the 3M team during COVID and why a pandemic is the perfect time to show IP worth
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Daleep Kumar of RNA, Technology and IP Attorneys explain how the Advertising Standards Council of India is acting to prevent misleading claims about coronavirus cures and remedies
-
Sponsored by Bird & BirdMax Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks ahead at the key deadlines in the South Korean drug patent market for 2021
